A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated Mothers
Completed · Phase 2 · NCT06143046
Conditions: Respiratory Syncytial Virus
At a glance
- Research payments reported, 2025
- $1.2M
- U.S. investigators named
- 17
- Sites paid
- 13
- Planned or actual enrollment
- 360
About the trial
- Sponsor
- ModernaTX, Inc.
- Tested
- mRNA-1345 (biological), Placebo (biological)
- Dates
- Started 2023-11-15; completion 2026-05-25
- Results posted
- Not yet
The purpose of the study is to evaluate the reactogenicity, safety, and immunogenicity of an investigational respiratory syncytial virus (RSV) vaccine, mRNA-1345, in pregnant women, and safety and immunogenicity in infants born to vaccinated mothers.
From ClinicalTrials.gov, last updated 2026-06-10. Full record, eligibility and contacts (opens in a new tab)
Industry funding
ModernaTX, Inc. reported $1.2M in research payments for this study in 2025 (689 payments).
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Guy M. Middleton, M.D. OB-GYN (Obstetrics & Gynecology) · Dothan, AL
- Nathan D. Livers, MD OB-GYN (Obstetrics & Gynecology) · Little Rock, AR
- Nicholas K. Bujak, MD OB-GYN (Obstetrics & Gynecology) · Phoenix, AZ
- Peyman Banooni, M.D. OB-GYN (Obstetrics & Gynecology) · Beverly Hills, CA
- Jose M. Diaz, M.D Pediatrics · Downey, CA
- Torri Metz, MD Maternal-Fetal Medicine (High-Risk Pregnancy) · Denver, CO
- Jeffrey B. Baker, M.D. Family Medicine · Idaho Falls, ID
- Heather D. Pugmire, M.D. OB-GYN (Obstetrics & Gynecology) · Blackfoot, ID
- William F. Beacham, M.D. OB-GYN (Obstetrics & Gynecology) · Hammond, LA
- Andrew S. Wagner, MD OB-GYN (Obstetrics & Gynecology) · Midland, MI
- Justin Buls, MD Family Medicine · Kalispell, MT
- Merlin B. Fausett, M.D. Maternal-Fetal Medicine (High-Risk Pregnancy) · Missoula, MT
- Alyson Miser, M.D. OB-GYN (Obstetrics & Gynecology) · Great Falls, MT
- Tyler J. Adam, M.D. OB-GYN (Obstetrics & Gynecology) · Hastings, NE
- Erica L. Haake, M.D. OB-GYN (Obstetrics & Gynecology) · Grand Island, NE
- Keith W. Vrbicky, M.D. OB-GYN (Obstetrics & Gynecology) · Norfolk, NE
- Salma Saiger, M.D. Internal Medicine · Mesquite, TX
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Matrix Clinical Research Inc $269,945
- Boeson Research LLC $255,821
- Sec Clinical Research LLC $177,941
- Applied Research Center of Arkansas $134,586
- Clinical Research Prime Idaho Falls LLC $133,157
- Abbys Clinic $65,616
- Velocity Clinical Research Inc $62,422
- Bmh Inc $45,202
- University of Utah Hospital and Clinics, UT $42,278
- Sms Clinical Research $4,735
- Saginaw Valley Medical Research Group LLC $2,516
- Sec Clinical Research $73
- Clinical Research Prime - Rexburg $19
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.